Compounds > 5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate
Page last updated: 2024-09-03

5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate and selfotel

5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate has been researched along with selfotel in 1 studies

Compound Research Comparison

Studies
(5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate)		Trials
(5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate)		Recent Studies (post-2010)
(5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate)		Studies
(selfotel)		Trials
(selfotel)		Recent Studies (post-2010) (selfotel)
1900250910

Protein Interaction Comparison

ProteinTaxonomy5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate (IC50)selfotel (IC50)
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)0.3428
Glutamate receptor 1Homo sapiens (human)0.967
Glutamate receptor 2Homo sapiens (human)0.967
Glutamate receptor 3Homo sapiens (human)0.967
Glutamate receptor 4Homo sapiens (human)0.967
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)0.362
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)0.3428
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)0.3428
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)0.3428
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)0.3428
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)0.3428

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gaspary, HL; Graham, SH; Simon, RP1

Other Studies

1 other study(ies) available for 5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate and selfotel

ArticleYear
BW1003C87 and NBQX but not CGS19755 reduce glutamate release and cerebral ischemic necrosis.
    European journal of pharmacology, 1994, Sep-12, Volume: 262, Issue:3

    Topics: Analysis of Variance; Animals; Binding, Competitive; Brain Ischemia; Disease Models, Animal; Glutamic Acid; Hippocampus; Injections, Intraperitoneal; Injections, Intravenous; Male; Microdialysis; N-Methylaspartate; Necrosis; Neurons; Observer Variation; Pipecolic Acids; Prosencephalon; Pyrimidines; Quinoxalines; Random Allocation; Rats; Rats, Wistar; Receptors, AMPA; Reperfusion Injury

1994